COMMUNIQUÉS West-GlobeNewswire

Golden Touch Fusion CBD Gummies: Official Product Information for Adults as the Federal Hemp Definition Changes November 12, 2026
14/10/2026
Total THC definition, 0.4 mg per-container limit, FDA-identified CBD gummies side effects, medication and pregnancy guidance, and customer care explained. El Cajon, CA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- These statements [...]
EmblemHealth Maintains 4-Star Medicare Rating, Highlighting Sustained Quality Performance
14/10/2026
EmblemHealth’s largest Medicare Advantage contract achieved a 4-star rating for the second consecutive year amid a national landscape where only 37% of comparable plans reached that threshold. NEW YORK, Oct. 14, 2026 ( [...]
Belite Bio Announces Multi-Market Submission of Marketing Authorization Applications Via the Access Consortium Pathway for Tinlarebant for the Treatment of Stargardt Disease Type 1
14/10/2026
If approved, tinlarebant would be the first-ever approved treatment for Stargardt Disease Type 1 in Singapore, United Kingdom, and Switzerland Access pathway submission combined with accepted new drug applications in [...]
Lakefront Announces Sale of Preclinical CAR-T Programs to Armed Cell Therapeutics
14/10/2026
Previously announced wind-down of the legacy cell therapy activities is substantially complete Mechelen, Belgium; October 14, 2026, 22.01 CEST; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced [...]
MannKind to Participate in the Chardan Healthcare Conference
14/10/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , today announced that Chief Executive Officer Michael Castagna will participate in a panel focused on [...]
MIMEDX to Host Third Quarter 2026 Operating and Financial Results Conference Call on October 28, 2026
14/10/2026
MARIETTA, Ga., Oct. 14, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the third quarter ended [...]
Teladoc Health to Announce Third Quarter 2026 Financial Results
14/10/2026
NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release third quarter 2026 results on Wednesday, October 28, 2026, after the market [...]
Adaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026
14/10/2026
SEATTLE, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]
Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
14/10/2026
Topline results expected mid-December 2026 REDWOOD CITY, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (Rezolute or Company), a late-stage ultra-rare disease company focused on treating [...]
Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
14/10/2026
Veteran biopharma CFO brings more than 15 years of public-company financial leadership across development, approval and commercial launch; joins Audit Committee LIBERTY CORNER, N.J., Oct. 14, 2026 (GLOBE NEWSWIRE) -- [...]
PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026
14/10/2026
MENLO PARK, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2026 financial results on Wednesday, November 4, [...]
Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14/10/2026
BOSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple [...]
Coherus Oncology to Host Webcast to Disclose Interim Tagmokitug Clinical Data on October 28, 2026
14/10/2026
REDWOOD CITY, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc . (Nasdaq: CHRS) today announced that the Company will release interim clinical data related to its tagmokitug development program evaluating [...]
Ossium Health Data on On-Demand Organ Donor Bone Marrow Selected as a Top Poster at the 2026 AABB Annual Meeting
14/10/2026
Updated data show stem cell viability is preserved through cryopreservation and 100% engraftment in evaluable transplant recipients SAN FRANCISCO, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Ossium Health, a bioengineering [...]
Elevar Therapeutics Resubmits New Drug Application to FDA for Combination of Camrelizumab plus Rivoceranib for Use as a First-line Treatment Option for Unresectable or Metastatic Hepatocellular Carcinoma
14/10/2026
Combination achieved mOS of 23.8 months in patients with unresectable or metastatic HCC FORT LEE, N.J., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a [...]
Leo International Precision Health AG: Mr. Leo Wang, Disposal
14/10/2026
Leo International Precision Health AG: Mr. Leo Wang, Disposal Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them, 14. Oct 2026 [...]
Leo International Precision Health AG: Mr Leo Wang, Disposal
14/10/2026
Leo International Precision Health AG: Mr Leo Wang, Disposal Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them, 14. Oct 2026 [...]
Valneva présentera ses activités et rencontrera les investisseurs lors de prochaines conférences santé aux États-Unis et en Europe
14/10/2026
Lyon (France), le 14 octobre 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que des membres de son équipe dirigeante feront des présentations et [...]
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
14/10/2026
Lyon (France), October 14, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in meetings with institutional [...]

Pages